|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-12-31
|
|
pubmed:abstractText |
A phase 3 study demonstrated that panitumumab, a human monoclonal anti-epidermal growth factor receptor antibody, significantly prolonged progression-free survival versus best supportive care (BSC) in patients with chemorefractory metastatic colorectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
pubmed-author:AmadoR GRG,
pubmed-author:BajettaEE,
pubmed-author:CanonJ-LJL,
pubmed-author:HoganNN,
pubmed-author:HumbletYY,
pubmed-author:KotasekDD,
pubmed-author:MaurerLL,
pubmed-author:NeynsBB,
pubmed-author:PeetersMM,
pubmed-author:SantoroAA,
pubmed-author:ScheithauerWW,
pubmed-author:SienaSS,
pubmed-author:SpadaforaSS,
pubmed-author:Van CutsemEE
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
92-8
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17785764-Adenocarcinoma,
pubmed-meshheading:17785764-Adult,
pubmed-meshheading:17785764-Aged,
pubmed-meshheading:17785764-Aged, 80 and over,
pubmed-meshheading:17785764-Antibodies, Monoclonal,
pubmed-meshheading:17785764-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17785764-Colorectal Neoplasms,
pubmed-meshheading:17785764-Disease Progression,
pubmed-meshheading:17785764-Disease-Free Survival,
pubmed-meshheading:17785764-Drug Eruptions,
pubmed-meshheading:17785764-Drug Resistance, Neoplasm,
pubmed-meshheading:17785764-Female,
pubmed-meshheading:17785764-Humans,
pubmed-meshheading:17785764-Immunotherapy,
pubmed-meshheading:17785764-Male,
pubmed-meshheading:17785764-Middle Aged,
pubmed-meshheading:17785764-Neoplasm Proteins,
pubmed-meshheading:17785764-Receptor, Epidermal Growth Factor,
pubmed-meshheading:17785764-Salvage Therapy,
pubmed-meshheading:17785764-Survival Analysis
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy.
|
|
pubmed:affiliation |
Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase III
|
